About Phase Holographic Imaging AB 
Phase Holographic Imaging AB
Pharmaceuticals & Biotechnology
Phase Holographic Imaging PHI AB (PHI) is a Sweden-based company active in the field of medical technology. It develops and markets time-lapse cytometers for clinical applications. The products use holographic microscopy technology, with image sensors capturing light information from objects, and computer processing the information to create visual image. It is also engaged in the development of related software. Its method allows to view and measure living cell over time, without disturbing or destroying it. PHI collaborates with cancer- and stem cell researchers, among others. The Company’s product portfolio includes HoloMonitor M3, a bench-top time-lapse cytometer, and HoloMonitor M4, allowing cell analysis in the cultivation incubator.
Company Coordinates 
Company Details
Scheelevagen 22 , LUND None : 223 63
Registrar Details
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Management
Designation
Mr. Mats Lundwall
Acting Chairman of the Board
Mr. Leland Foster
Director
Mr. Johan Hyllner
Director
Ms. Maria Morin
Director
Ms. Linda Neckmar
Director
Mr. Jan Richardsson
Director
Revenue and Profits:
Net Sales:
6 Million
(Quarterly Results - Jan 2025)
Net Profit:
-3 Million
Pharmaceuticals & Biotechnology
SEK 51 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.27
-50.29%
1.28






